Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Complete Genome Sequence of a Novel Human Papillomavirus Isolated from Oral Rinse.

Chen Z, Wong MCS, Wong PY, Ho WCS, Liang M, Yeung ACM, Chan PKS.

Genome Announc. 2017 Nov 9;5(45). pii: e01281-17. doi: 10.1128/genomeA.01281-17.

2.

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, Steinberg M, Burdett L, Dean M, Roberson D, Mitchell J, Lorey T, Franceschi S, Castle PE, Walker J, Zuna R, Kreimer AR, Beachler DC, Hildesheim A, Gonzalez P, Porras C, Burk RD, Schiffman M.

Cell. 2017 Sep 7;170(6):1164-1174.e6. doi: 10.1016/j.cell.2017.08.001.

PMID:
28886384
3.

Ancient Evolution and Dispersion of Human Papillomavirus 58 Variants.

Chen Z, Ho WCS, Boon SS, Law PTY, Chan MCW, DeSalle R, Burk RD, Chan PKS.

J Virol. 2017 Oct 13;91(21). pii: e01285-17. doi: 10.1128/JVI.01285-17. Print 2017 Nov 1.

4.

Interactome analysis of gene expression profiles of cervical cancer reveals dysregulated mitotic gene clusters.

Cheng J, Lu X, Wang J, Zhang H, Duan P, Li C.

Am J Transl Res. 2017 Jun 15;9(6):3048-3059. eCollection 2017.

5.

High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.

Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH.

J Gynecol Oncol. 2017 Jul;28(4):e30. doi: 10.3802/jgo.2017.28.e30.

6.

Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women.

Tang Y, Zheng L, Yang S, Li B, Su H, Zhang LP.

Virol J. 2017 Apr 21;14(1):84. doi: 10.1186/s12985-017-0751-3.

7.

Six-year multi-centre, observational, post-marketing surveillance of the safety of the HPV-16/18 AS04-adjuvanted vaccine in women aged 10-25 years in Korea.

Kim CJ, Song R, Chen J, Tavares Da Silva F, Gopala KB, Kim JH, Bi D, Park JS.

Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):837-842. doi: 10.1002/pds.4175. Epub 2017 Mar 7.

8.

Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.

Fontecha N, Basaras M, Hernáez S, Andía D, Cisterna R.

BMC Cancer. 2016 Nov 5;16(1):852.

10.

High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.

White EA, Münger K, Howley PM.

MBio. 2016 Sep 20;7(5). pii: e01530-16. doi: 10.1128/mBio.01530-16.

11.

Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR.

Chanthavilay P, Reinharz D, Mayxay M, Phongsavan K, Marsden DE, Moore L, White LJ.

PLoS One. 2016 Sep 15;11(9):e0162915. doi: 10.1371/journal.pone.0162915. eCollection 2016.

12.

TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.

Manawapat-Klopfer A, Thomsen LT, Martus P, Munk C, Russ R, Gmuender H, Frederiksen K, Haedicke-Jarboui J, Stubenrauch F, Kjaer SK, Iftner T.

Am J Cancer Res. 2016 Jul 1;6(7):1524-36. eCollection 2016.

13.

Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia.

Gebremariam T.

Int J Health Sci (Qassim). 2016 Jan;10(1):137-43. Review.

14.

Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study.

Shaw E, Ramanakumar AV, El-Zein M, Silva FR, Galan L, Baggio ML, Villa LL, Franco EL; Ludwig-McGill Cohort Study.

BMC Infect Dis. 2016 Mar 8;16:116. doi: 10.1186/s12879-016-1446-x.

15.

Molecular diagnosis and phylogenetic analysis of human papillomavirus type-16 from suspected patients in Pakistan.

Abdullah A, Qasim M, Shafiq M, Ijaz M, Parveen S, Murtaza S, Javed Q, Malik SA, Tarar SH, Mehmood S, Sami A, Naqvi SM, Hyder MZ.

Infect Agent Cancer. 2016 Jan 12;11:1. doi: 10.1186/s13027-016-0047-z. eCollection 2016.

16.

A Suggested Approach to Simplify and Improve Cervical Screening in the United States.

Schiffman M, Wentzensen N.

J Low Genit Tract Dis. 2016 Jan;20(1):1-7. doi: 10.1097/LGT.0000000000000170.

17.

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

Skinner SR, Wheeler CM, Romanowski B, Castellsagué X, Lazcano-Ponce E, Del Rosario-Raymundo MR, Vallejos C, Minkina G, Pereira Da Silva D, McNeil S, Prilepskaya V, Gogotadze I, Money D, Garland SM, Romanenko V, Harper DM, Levin MJ, Chatterjee A, Geeraerts B, Struyf F, Dubin G, Bozonnat MC, Rosillon D, Baril L; VIVIANE Study Group.

Int J Cancer. 2016 May 15;138(10):2428-38. doi: 10.1002/ijc.29971.

18.

Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.

Da Silva DM, Woodham AW, Rijkee LK, Skeate JG, Taylor JR, Koopman ME, Brand HE, Wong MK, McKee GM, Salazar AM, Kast WM.

Papillomavirus Res. 2015 Dec 1;1:12-21. doi: 10.1016/j.pvr.2015.05.001.

19.

Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy.

Trottier H, Mayrand MH, Baggio ML, Galan L, Ferenczy A, Villa LL, Franco EL; Ludwig-McGill Cohort Study Group.

BMC Pregnancy Childbirth. 2015 Oct 7;15:244. doi: 10.1186/s12884-015-0675-0.

20.

Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, Peru.

Rosen BJ, Walter L, Gilman RH, Cabrerra L, Gravitt PE, Marks MA.

Sex Transm Infect. 2016 Mar;92(2):149-54. doi: 10.1136/sextrans-2014-051942. Epub 2015 Aug 14.

Supplemental Content

Support Center